Literature DB >> 15812608

Drug treatment modalities in psychiatric inpatient practice: a 20-year comparison.

Corrado Barbui1, Arcangelo Ciuna, Michela Nosè, Deborah Levi, Margherita Andretta, Scott B Patten, Francesco Amaddeo, Michele Tansella.   

Abstract

OBJECTIVES: The present study investigated whether the increased number of psychotropic agents available in Italy in the last 20 years increased the proportion of inpatients being treated with individual medication classes and the proportion receiving combined treatments with agents of the same class or of different classes.
METHODS: This study was conducted in South-Verona, Italy. From the local Psychiatric Case Register (PCR) all patients consecutively admitted to the inpatient unit during the years 1981/1982, 1991/92 and 2001/02 were extracted. Drug use at discharge was derived from clinical records, while service use data were extracted from the PCR.
RESULTS: During the six years surveyed 160 patients were admitted in 1981/82, 139 in 1991/92 and 228 in 2001/02. An increasing proportion of subjects receiving antipsychotic, antidepressant and benzodiazepine treatment at discharge was observed. In addition, we found an increasing proportion of patients receiving two or more psychotropic drugs at discharge, which accounted for almost 80% of cases in 2001/02. The number of psychotropic agents prescribed at hospital discharge was positively correlated with the total consumption of psychotropic drugs. A relevant proportion of patients were also dispensed agents for medical conditions, yielding an average number of 3.2 prescriptions in 2001/02. The Lavik score, a summary index of service use, indicated that subjects admitted in 1981/82 were moderate users of psychiatric services, while those admitted in 1991/92 and in 2001/02 were high users of psychiatric services.
CONCLUSION: This study documented emerging trends toward polypharmacotherapy and higher total doses. Additional pharmacoepidemiological research is needed to clarify both the beneficial and, potentially, adverse effects associated with these trends in psychiatric pharmacotherapy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15812608     DOI: 10.1007/s00406-004-0546-6

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  21 in total

1.  Selective serotonin reuptake inhibitors have broadened the utilisation of antidepressant treatment in accordance with recommendations. Findings from a Swedish prescription database.

Authors:  G Isacsson; G Boëthius; S Henriksson; J K Jones; U Bergman
Journal:  J Affect Disord       Date:  1999-04       Impact factor: 4.839

2.  Combination antipsychotics: pros, cons, and questions.

Authors:  Alexander L Miller; Catherine S Craig
Journal:  Schizophr Bull       Date:  2002       Impact factor: 9.306

3.  Antidepressant drug use in Italy since the introduction of SSRIs: national trends, regional differences and impact on suicide rates.

Authors:  C Barbui; A Campomori; B D'Avanzo; E Negri; S Garattini
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1999-03       Impact factor: 4.328

4.  Integrating evaluative research and community-based mental health care in Verona, Italy.

Authors:  Michele Tansella; Lorenzo Burti
Journal:  Br J Psychiatry       Date:  2003-08       Impact factor: 9.319

5.  Inpatient antipsychotic drug use in 1998, 1993, and 1989.

Authors:  Franca Centorrino; Marion Eakin; Won-Myong Bahk; James P Kelleher; Jessica Goren; Paola Salvatore; Samy Egli; Ross J Baldessarini
Journal:  Am J Psychiatry       Date:  2002-11       Impact factor: 18.112

6.  Off-label use of antipsychotic drugs.

Authors:  E Weiss; M Hummer; D Koller; H Ulmer; W W Fleischhacker
Journal:  J Clin Psychopharmacol       Date:  2000-12       Impact factor: 3.153

7.  Utilization of mental health services over a given period.

Authors:  N J Lavik
Journal:  Acta Psychiatr Scand       Date:  1983-06       Impact factor: 6.392

8.  Are we going to increase the use of antidepressants up to that of benzodiazepines?

Authors:  Arcangelo Ciuna; Margherita Andretta; Letizia Corbari; Deborah Levi; Mersia Mirandola; Adriano Sorio; Corrado Barbui
Journal:  Eur J Clin Pharmacol       Date:  2004-09-23       Impact factor: 2.953

9.  Prescribing second-generation antipsychotics and the evolving standard of care in Italy.

Authors:  C Barbui; A Danese; G Guaiana; L Mapelli; L Miele; E Monzani; M Percudani
Journal:  Pharmacopsychiatry       Date:  2002-11       Impact factor: 5.788

10.  Trends in the rate and type of antipsychotic medications prescribed to persons with schizophrenia.

Authors:  Aileen B Rothbard; Eri Kuno; Kathy Foley
Journal:  Schizophr Bull       Date:  2003       Impact factor: 9.306

View more
  1 in total

1.  Treatment patterns in inpatient depression care.

Authors:  Alessa von Wolff; Ramona Meister; Martin Härter; Levente Kriston
Journal:  Int J Methods Psychiatr Res       Date:  2015-08-18       Impact factor: 4.035

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.